The Effect of GnRH Administration During Luteal Support in Frozen-thawed Transfer Cycles
- Conditions
- Pregnancy Rate
- Registration Number
- NCT01933009
- Lead Sponsor
- Assaf-Harofeh Medical Center
- Brief Summary
GnRH administration during the luteal phase was found to significantly increase pregnancy rates in women undergoing fresh-cycle IVF cycles.
We aim to investigate the effect of GnRH administration during the luteal phase in women undergoing frozen-thawed IVF cycles.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- Female
- Target Recruitment
- 100
Inclusion Criteria
Frozen-thawed IVF cycles
Exclusion Criteria
Hydrosalpings Uterine myomas
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pregnancy rate 1 year
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms explain GnRH's impact on luteal phase support in frozen-thawed IVF cycles?
How does GnRH administration compare to standard luteal support protocols in frozen-thawed embryo transfer?
Are there specific biomarkers that predict response to GnRH in frozen-thawed IVF cycles?
What are the potential adverse events associated with GnRH use during luteal support in frozen-thawed transfers?
What combination therapies or alternative drugs are being explored alongside GnRH for improved pregnancy outcomes in frozen-thawed IVF?
Trial Locations
- Locations (1)
IVF and infertility unit, Assaf Harofeh Medical Center
🇮🇱Zerifin, Be'er-Ya'akov, Israel
IVF and infertility unit, Assaf Harofeh Medical Center🇮🇱Zerifin, Be'er-Ya'akov, IsraelIdo Ben-Ami, MD, PhDContact